M.A.M. Overbeeke

2.6k total citations
54 papers, 1.5k citations indexed

About

M.A.M. Overbeeke is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, M.A.M. Overbeeke has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 31 papers in Physiology and 14 papers in Genetics. Recurrent topics in M.A.M. Overbeeke's work include Blood groups and transfusion (50 papers), Erythrocyte Function and Pathophysiology (31 papers) and Blood disorders and treatments (11 papers). M.A.M. Overbeeke is often cited by papers focused on Blood groups and transfusion (50 papers), Erythrocyte Function and Pathophysiology (31 papers) and Blood disorders and treatments (11 papers). M.A.M. Overbeeke collaborates with scholars based in Netherlands, United Kingdom and United States. M.A.M. Overbeeke's co-authors include C. Ellen van der Schoot, B. H. W. Faas, A. E. G. Kr. von dem Borne, D.J. van Rhenen, Erik A.M. Beckers, C. P. Engelfriet, Peter C. Ligthart, Joyce Poole, Willem H. Ouwehand and Loek van Alphen and has published in prestigious journals such as The Lancet, American Journal of Obstetrics and Gynecology and British Journal of Haematology.

In The Last Decade

M.A.M. Overbeeke

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.A.M. Overbeeke Netherlands	23	1.3k	825	329	291	271	54	1.5k
F. Schunter Germany	12	799 0.6×	571 0.7×	326 1.0×	195 0.7×	98 0.4×	39	1.0k
Christine Lomas‐Francis United States	18	1.3k 1.0×	1.1k 1.3×	287 0.9×	531 1.8×	127 0.5×	98	1.6k
G.L. Daniels United Kingdom	17	644 0.5×	535 0.6×	229 0.7×	179 0.6×	67 0.2×	36	949
Andrew G. Hadley United Kingdom	20	573 0.4×	290 0.4×	215 0.7×	90 0.3×	130 0.5×	42	962
H.‐H. Sonneborn Germany	15	321 0.3×	298 0.4×	97 0.3×	73 0.3×	38 0.1×	43	786
Priscilla Yam United States	16	501 0.4×	58 0.1×	352 1.1×	138 0.5×	67 0.2×	26	1.3k
JL Abkowitz United States	14	340 0.3×	82 0.1×	243 0.7×	146 0.5×	18 0.1×	22	776
Fabien Touzot France	21	192 0.1×	230 0.3×	261 0.8×	102 0.4×	40 0.1×	45	1.2k
Boris Calmels France	20	718 0.6×	48 0.1×	402 1.2×	169 0.6×	48 0.2×	78	1.4k
Benoît Vingert France	17	224 0.2×	151 0.2×	60 0.2×	164 0.6×	18 0.1×	39	916

Countries citing papers authored by M.A.M. Overbeeke

Since Specialization

Citations

This map shows the geographic impact of M.A.M. Overbeeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A.M. Overbeeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A.M. Overbeeke more than expected).

Fields of papers citing papers by M.A.M. Overbeeke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A.M. Overbeeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A.M. Overbeeke. The network helps show where M.A.M. Overbeeke may publish in the future.

Co-authorship network of co-authors of M.A.M. Overbeeke

This figure shows the co-authorship network connecting the top 25 collaborators of M.A.M. Overbeeke. A scholar is included among the top collaborators of M.A.M. Overbeeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A.M. Overbeeke. M.A.M. Overbeeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dijk, Boukje A. C. van, R.A. Hirasing, & M.A.M. Overbeeke. (1999). [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].. PubMed. 143(28). 1465–9. 7 indexed citations

Case, John, Amy W. Chung, Toshio Mazda, et al.. (1999). International Reference Reagents: Antihuman Globulin. Vox Sanguinis. 77(2). 121–127. 1 indexed citations

Wijk, Petra A. Maaskant‐van, B. H. W. Faas, M.A.M. Overbeeke, et al.. (1998). Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD‐specific exons. Transfusion. 38(11-12). 1015–1021. 103 indexed citations

Faas, B. H. W., Erik A.M. Beckers, Peter C. Ligthart, et al.. (1997). Molecular background of VS and weak C expression in blacks. Transfusion. 37(1). 38–44. 141 indexed citations

Faas, B. H. W., et al.. (1997). Involvement of Gly96 in the formation of the Rh26 epitope. Transfusion. 37(11-12). 1123–1130. 22 indexed citations

Beckers, Erik A.M., et al.. (1996). The R₀^Har Rh:33 phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RHD gene. British Journal of Haematology. 92(3). 751–757. 51 indexed citations

Beckers, Erik A.M., B. H. W. Faas, Suat Şimşek, et al.. (1996). The genetic basis of a new partial D antigen: D^DBT. British Journal of Haematology. 93(3). 720–727. 47 indexed citations

Wijk, Petra A. Maaskant‐van, B. H. W. Faas, Peter C. Ligthart, et al.. (1996). Rh DNA analysis. Transfusion Clinique et Biologique. 3(6). 507–510. 4 indexed citations

Beckers, Erik A.M., B. H. W. Faas, Peter C. Ligthart, et al.. (1996). Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype. Transfusion. 36(6). 567–574. 34 indexed citations

10.

Daniels, Geoff, et al.. (1996). A New Low‐Incidence Antigen in the Kell Blood Group System: VLAN (KEL25). Vox Sanguinis. 71(1). 43–47. 4 indexed citations

11.

Dijk, Boukje A. C. van, et al.. (1995). Red cell antibodies in pregnancy: there is no ‘critical titre’. Transfusion Medicine. 5(3). 199–202. 33 indexed citations

12.

Şimşek, Serkan, et al.. (1994). Sequence Analysis of cDNA Derived from Reticulocyte mRNAs Coding for Rh Polypeptides and Demonstration of E/e and C/c Polymorphisms. Vox Sanguinis. 67(2). 203–209. 62 indexed citations

13.

Rhenen, D.J. van, et al.. (1994). Serological Characteristics of Partial D Antigen Category VI in 8 Unrelated Blood Donors. Vox Sanguinis. 66(2). 133–136. 10 indexed citations

14.

Overbeeke, M.A.M., et al.. (1994). Autoimmune haemolytic anaemia during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 55(3). 209–211. 13 indexed citations

15.

Novotný, V.M.J., et al.. (1992). Misleading Results in the Determination of Haemolytic Disease of the Newborn Using Antibody Titration and ADCC in a Woman with Anti‐Lub. Vox Sanguinis. 62(1). 49–52. 5 indexed citations

16.

Hoffmann, Johannes J.M.L., et al.. (1990). A New, Low‐Incidence Red Cell Antigen (HOFM), Associated with Depressed C Antigen. Vox Sanguinis. 59(4). 240–243. 2 indexed citations

17.

Rhenen, D.J. van, et al.. (1989). Testing Efficacy of Anti‐D Sera by a Panel of Donor Red Cells with Weak Reacting D Antigen and with Partial D Antigens. Vox Sanguinis. 56(4). 274–277. 9 indexed citations

18.

Redman, Colvin M., et al.. (1988). Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen. British Journal of Haematology. 68(1). 131–136. 45 indexed citations

19.

Brouwers, H. A. A., et al.. (1988). Complement is not activated in ABO‐haemolytic disease of the newborn. British Journal of Haematology. 68(3). 363–366. 15 indexed citations

20.

Brouwers, H. A. A., M.A.M. Overbeeke, Willem H. Ouwehand, et al.. (1988). Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte‐driven cytotoxicity and correlation with ABO haemolytic disease of the newborn. British Journal of Haematology. 70(4). 465–469. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact